Post-approval studies (Phase 4)Looking for participantsNCT06646562
What this trial is testing
Long Acting Cabotegravir Plus Rilpivirine in People Living with HIV-1 Aged ≥ 60 Years for 24 Months.
Who this might be right for
HIV-1 Infected Adults with Controlled Viremia
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia 120